Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Lipoprotein(a) | 25 | 2024 | 488 | 7.300 |
Why?
|
Coronary Artery Disease | 55 | 2025 | 6573 | 6.810 |
Why?
|
Cardiovascular Diseases | 61 | 2025 | 15645 | 4.330 |
Why?
|
Genome-Wide Association Study | 83 | 2025 | 12790 | 3.420 |
Why?
|
Menopause, Premature | 6 | 2023 | 124 | 3.400 |
Why?
|
Multifactorial Inheritance | 22 | 2024 | 1422 | 3.100 |
Why?
|
Mendelian Randomization Analysis | 22 | 2025 | 1040 | 2.890 |
Why?
|
Atherosclerosis | 27 | 2024 | 3418 | 2.810 |
Why?
|
Hematopoiesis | 26 | 2024 | 2056 | 2.730 |
Why?
|
Dioxygenases | 11 | 2024 | 353 | 2.160 |
Why?
|
Hypertension | 13 | 2024 | 8615 | 1.940 |
Why?
|
Genetic Predisposition to Disease | 61 | 2025 | 18063 | 1.930 |
Why?
|
Primary Prevention | 7 | 2022 | 1188 | 1.820 |
Why?
|
Lipids | 16 | 2024 | 3322 | 1.800 |
Why?
|
Risk Factors | 109 | 2025 | 74886 | 1.780 |
Why?
|
Phospholipids | 5 | 2024 | 778 | 1.720 |
Why?
|
Receptors, Interleukin-6 | 5 | 2023 | 224 | 1.700 |
Why?
|
Cholesterol, LDL | 29 | 2024 | 2392 | 1.680 |
Why?
|
Hematopoietic Stem Cells | 17 | 2024 | 3408 | 1.530 |
Why?
|
Hyperlipoproteinemia Type II | 10 | 2025 | 396 | 1.490 |
Why?
|
Polymorphism, Single Nucleotide | 45 | 2025 | 16036 | 1.440 |
Why?
|
Oxidation-Reduction | 4 | 2024 | 2221 | 1.360 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 10 | 2024 | 3249 | 1.300 |
Why?
|
Hypertension, Pregnancy-Induced | 4 | 2024 | 529 | 1.280 |
Why?
|
Vascular Diseases | 5 | 2024 | 1161 | 1.260 |
Why?
|
Humans | 286 | 2025 | 767040 | 1.230 |
Why?
|
Apolipoprotein B-100 | 5 | 2024 | 157 | 1.220 |
Why?
|
Genetic Variation | 17 | 2024 | 6611 | 1.210 |
Why?
|
Triglycerides | 14 | 2024 | 2444 | 1.200 |
Why?
|
Coronary Disease | 16 | 2023 | 5914 | 1.190 |
Why?
|
Pre-Eclampsia | 5 | 2024 | 1255 | 1.140 |
Why?
|
Venous Thromboembolism | 8 | 2024 | 1883 | 1.140 |
Why?
|
Biological Specimen Banks | 14 | 2024 | 787 | 1.110 |
Why?
|
Germ-Line Mutation | 5 | 2024 | 1885 | 1.100 |
Why?
|
Pregnancy Complications, Cardiovascular | 2 | 2022 | 519 | 1.040 |
Why?
|
Mutation | 38 | 2024 | 30211 | 1.030 |
Why?
|
Cholesterol Ester Transfer Proteins | 4 | 2023 | 113 | 1.030 |
Why?
|
Pneumonia | 3 | 2022 | 2159 | 0.990 |
Why?
|
Middle Aged | 103 | 2025 | 223233 | 0.950 |
Why?
|
Blood Pressure | 13 | 2024 | 8531 | 0.950 |
Why?
|
Dyslipidemias | 4 | 2024 | 872 | 0.930 |
Why?
|
Manipulation, Osteopathic | 1 | 2024 | 3 | 0.930 |
Why?
|
Female | 143 | 2025 | 396660 | 0.900 |
Why?
|
Heart Failure | 14 | 2024 | 11877 | 0.890 |
Why?
|
Genome, Human | 8 | 2021 | 4441 | 0.880 |
Why?
|
Coronary Vessel Anomalies | 2 | 2024 | 308 | 0.880 |
Why?
|
Risk Assessment | 23 | 2025 | 24299 | 0.840 |
Why?
|
Coronary Angiography | 8 | 2025 | 4525 | 0.840 |
Why?
|
Chromosomes, Human, X | 2 | 2024 | 319 | 0.830 |
Why?
|
Eclampsia | 1 | 2023 | 61 | 0.820 |
Why?
|
Apolipoprotein C-III | 4 | 2024 | 209 | 0.820 |
Why?
|
Male | 127 | 2025 | 364203 | 0.810 |
Why?
|
Photoplethysmography | 2 | 2020 | 66 | 0.810 |
Why?
|
Hypercholesterolemia | 8 | 2024 | 1144 | 0.800 |
Why?
|
Atrial Fibrillation | 10 | 2024 | 5180 | 0.790 |
Why?
|
Aging | 8 | 2024 | 8729 | 0.770 |
Why?
|
Genetic Pleiotropy | 2 | 2022 | 181 | 0.770 |
Why?
|
Life Style | 7 | 2024 | 3931 | 0.750 |
Why?
|
Hepatitis | 1 | 2023 | 226 | 0.740 |
Why?
|
Aged | 69 | 2025 | 171319 | 0.740 |
Why?
|
Diabetes Mellitus, Type 2 | 21 | 2024 | 12250 | 0.720 |
Why?
|
Hypertension, Pulmonary | 2 | 2022 | 1604 | 0.720 |
Why?
|
Myocardial Infarction | 15 | 2024 | 11513 | 0.710 |
Why?
|
Peripheral Arterial Disease | 5 | 2024 | 1304 | 0.700 |
Why?
|
Parasympathetic Nervous System | 1 | 2020 | 144 | 0.690 |
Why?
|
Secondary Prevention | 3 | 2024 | 1472 | 0.670 |
Why?
|
Aortic Aneurysm, Thoracic | 2 | 2023 | 707 | 0.670 |
Why?
|
Cholesterol, HDL | 9 | 2024 | 1816 | 0.660 |
Why?
|
Hyperlipoproteinemias | 1 | 2019 | 20 | 0.650 |
Why?
|
Disease Susceptibility | 2 | 2023 | 1791 | 0.640 |
Why?
|
Aortic Valve Stenosis | 7 | 2024 | 2021 | 0.640 |
Why?
|
Adult | 75 | 2024 | 223317 | 0.630 |
Why?
|
Menopause | 4 | 2023 | 1655 | 0.620 |
Why?
|
Genomics | 12 | 2025 | 5924 | 0.620 |
Why?
|
Genetics, Population | 3 | 2024 | 943 | 0.610 |
Why?
|
Metabolomics | 3 | 2024 | 1675 | 0.610 |
Why?
|
Incidence | 16 | 2024 | 21526 | 0.610 |
Why?
|
Proteomics | 4 | 2024 | 3913 | 0.610 |
Why?
|
DNA-Binding Proteins | 13 | 2024 | 9612 | 0.610 |
Why?
|
Postmenopause | 4 | 2023 | 2518 | 0.610 |
Why?
|
Microvessels | 2 | 2024 | 585 | 0.600 |
Why?
|
Phenotype | 28 | 2025 | 16718 | 0.600 |
Why?
|
Microcirculation | 2 | 2024 | 1282 | 0.590 |
Why?
|
Proto-Oncogene Proteins | 8 | 2024 | 4522 | 0.580 |
Why?
|
Sympathetic Nervous System | 1 | 2020 | 521 | 0.580 |
Why?
|
Cardiology Service, Hospital | 1 | 2019 | 242 | 0.570 |
Why?
|
Monitoring, Ambulatory | 1 | 2020 | 357 | 0.570 |
Why?
|
Electronic Health Records | 5 | 2024 | 4881 | 0.570 |
Why?
|
Ventricular Remodeling | 3 | 2024 | 1281 | 0.560 |
Why?
|
Gonadal Steroid Hormones | 1 | 2021 | 707 | 0.550 |
Why?
|
Apolipoproteins | 1 | 2019 | 328 | 0.550 |
Why?
|
Carotid Stenosis | 1 | 2024 | 858 | 0.540 |
Why?
|
C-Reactive Protein | 4 | 2024 | 3851 | 0.540 |
Why?
|
Renal Insufficiency, Chronic | 4 | 2024 | 2299 | 0.530 |
Why?
|
Apolipoprotein A-I | 4 | 2023 | 305 | 0.520 |
Why?
|
Fingers | 1 | 2019 | 508 | 0.520 |
Why?
|
Veterans | 10 | 2024 | 2666 | 0.510 |
Why?
|
Plaque, Atherosclerotic | 2 | 2024 | 1549 | 0.500 |
Why?
|
Janus Kinase 2 | 3 | 2024 | 561 | 0.500 |
Why?
|
RNA, Small Interfering | 2 | 2024 | 3427 | 0.490 |
Why?
|
Risk Reduction Behavior | 1 | 2022 | 1119 | 0.490 |
Why?
|
Prospective Studies | 24 | 2024 | 54886 | 0.490 |
Why?
|
Lipid Metabolism | 5 | 2021 | 1895 | 0.490 |
Why?
|
Cohort Studies | 24 | 2024 | 41718 | 0.490 |
Why?
|
Models, Genetic | 5 | 2024 | 3445 | 0.480 |
Why?
|
Lipoproteins, HDL | 4 | 2023 | 679 | 0.480 |
Why?
|
Penetrance | 1 | 2016 | 388 | 0.470 |
Why?
|
Sex Characteristics | 4 | 2024 | 2647 | 0.450 |
Why?
|
Interleukin-6 | 3 | 2024 | 3227 | 0.450 |
Why?
|
Disease Progression | 5 | 2024 | 13646 | 0.450 |
Why?
|
Hematologic Neoplasms | 5 | 2024 | 1907 | 0.450 |
Why?
|
Cardiovascular System | 1 | 2021 | 839 | 0.450 |
Why?
|
Proteome | 5 | 2024 | 1890 | 0.440 |
Why?
|
Disease Management | 3 | 2022 | 2531 | 0.440 |
Why?
|
Genetic Association Studies | 9 | 2022 | 2744 | 0.430 |
Why?
|
Anticholesteremic Agents | 2 | 2022 | 969 | 0.430 |
Why?
|
Coronary Stenosis | 1 | 2019 | 803 | 0.420 |
Why?
|
Health Status | 4 | 2023 | 4091 | 0.420 |
Why?
|
Asymptomatic Diseases | 3 | 2024 | 588 | 0.420 |
Why?
|
Clone Cells | 3 | 2024 | 1669 | 0.410 |
Why?
|
Communicable Diseases | 1 | 2021 | 872 | 0.410 |
Why?
|
Inflammation | 6 | 2024 | 10869 | 0.410 |
Why?
|
Liver Cirrhosis | 1 | 2023 | 1959 | 0.400 |
Why?
|
Stroke | 7 | 2024 | 9746 | 0.400 |
Why?
|
Coronary Vessels | 3 | 2024 | 3114 | 0.400 |
Why?
|
Genotype | 16 | 2024 | 13035 | 0.390 |
Why?
|
Chromosome Aberrations | 4 | 2022 | 1776 | 0.390 |
Why?
|
Lipoproteins | 4 | 2021 | 871 | 0.390 |
Why?
|
Retina | 2 | 2024 | 2659 | 0.380 |
Why?
|
Hypolipidemic Agents | 3 | 2021 | 609 | 0.370 |
Why?
|
Acute Kidney Injury | 1 | 2023 | 1946 | 0.370 |
Why?
|
National Heart, Lung, and Blood Institute (U.S.) | 3 | 2021 | 325 | 0.360 |
Why?
|
Quantitative Trait Loci | 7 | 2024 | 2131 | 0.360 |
Why?
|
Carotid Artery Diseases | 1 | 2016 | 872 | 0.350 |
Why?
|
Inflammasomes | 3 | 2024 | 540 | 0.340 |
Why?
|
Stroke Volume | 5 | 2024 | 5618 | 0.340 |
Why?
|
Gene Frequency | 6 | 2021 | 3621 | 0.340 |
Why?
|
Receptors, LDL | 7 | 2024 | 492 | 0.330 |
Why?
|
Women's Health | 5 | 2024 | 2082 | 0.330 |
Why?
|
Mosaicism | 2 | 2024 | 480 | 0.320 |
Why?
|
Repressor Proteins | 5 | 2024 | 2979 | 0.320 |
Why?
|
Heart Ventricles | 2 | 2022 | 3837 | 0.320 |
Why?
|
DNA Damage | 1 | 2019 | 2469 | 0.320 |
Why?
|
Heart Rate | 1 | 2020 | 4209 | 0.320 |
Why?
|
Predictive Value of Tests | 6 | 2024 | 15424 | 0.310 |
Why?
|
HIV Infections | 3 | 2024 | 17542 | 0.310 |
Why?
|
Cause of Death | 1 | 2019 | 3717 | 0.300 |
Why?
|
Apolipoproteins B | 4 | 2023 | 385 | 0.300 |
Why?
|
Mass Screening | 2 | 2021 | 5456 | 0.300 |
Why?
|
Proportional Hazards Models | 6 | 2024 | 12536 | 0.300 |
Why?
|
Diabetes Mellitus, Type 1 | 1 | 2022 | 3449 | 0.290 |
Why?
|
Medical History Taking | 2 | 2022 | 779 | 0.290 |
Why?
|
Odds Ratio | 7 | 2023 | 9660 | 0.280 |
Why?
|
Animals | 33 | 2024 | 168965 | 0.280 |
Why?
|
Sepsis | 1 | 2021 | 2605 | 0.280 |
Why?
|
Cost of Illness | 1 | 2017 | 1951 | 0.280 |
Why?
|
Hyperlipidemias | 2 | 2024 | 771 | 0.270 |
Why?
|
Mutation, Missense | 6 | 2024 | 2592 | 0.270 |
Why?
|
United States | 20 | 2024 | 72971 | 0.260 |
Why?
|
Heart Diseases | 3 | 2024 | 2817 | 0.260 |
Why?
|
Pregnancy | 10 | 2024 | 30238 | 0.260 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2018 | 3667 | 0.260 |
Why?
|
Gene Expression Profiling | 3 | 2024 | 9532 | 0.260 |
Why?
|
Lipase | 2 | 2021 | 320 | 0.250 |
Why?
|
Genetic Loci | 3 | 2021 | 2629 | 0.250 |
Why?
|
Mice | 24 | 2024 | 81912 | 0.250 |
Why?
|
Cross-Sectional Studies | 11 | 2024 | 26325 | 0.250 |
Why?
|
Medical Staff, Hospital | 1 | 2009 | 602 | 0.250 |
Why?
|
Disease | 3 | 2024 | 675 | 0.250 |
Why?
|
Hormone Replacement Therapy | 2 | 2022 | 756 | 0.250 |
Why?
|
Prognosis | 7 | 2024 | 29963 | 0.240 |
Why?
|
Antihypertensive Agents | 3 | 2023 | 2030 | 0.240 |
Why?
|
Thrombosis | 3 | 2024 | 2954 | 0.230 |
Why?
|
Practice Guidelines as Topic | 3 | 2022 | 7435 | 0.230 |
Why?
|
Calcinosis | 2 | 2023 | 1481 | 0.230 |
Why?
|
Acute Coronary Syndrome | 2 | 2021 | 2193 | 0.220 |
Why?
|
Longitudinal Studies | 5 | 2024 | 14766 | 0.220 |
Why?
|
Apoprotein(a) | 1 | 2023 | 17 | 0.220 |
Why?
|
Influenza Vaccines | 1 | 2011 | 780 | 0.220 |
Why?
|
Genome | 2 | 2022 | 1752 | 0.210 |
Why?
|
Diet | 1 | 2021 | 8089 | 0.210 |
Why?
|
Colchicine | 1 | 2024 | 256 | 0.210 |
Why?
|
Leisure Activities | 1 | 2025 | 310 | 0.210 |
Why?
|
Telemedicine | 1 | 2020 | 3110 | 0.210 |
Why?
|
Apolipoproteins A | 1 | 2023 | 95 | 0.210 |
Why?
|
Case-Control Studies | 16 | 2022 | 22254 | 0.210 |
Why?
|
Cold-Shock Response | 1 | 2022 | 16 | 0.210 |
Why?
|
Alleles | 6 | 2024 | 6893 | 0.210 |
Why?
|
Sequence Analysis, DNA | 5 | 2021 | 4780 | 0.210 |
Why?
|
Heterozygote | 6 | 2021 | 2794 | 0.200 |
Why?
|
Radon | 1 | 2024 | 91 | 0.200 |
Why?
|
Blood Proteins | 2 | 2024 | 1190 | 0.200 |
Why?
|
Cholesterol | 4 | 2024 | 2905 | 0.190 |
Why?
|
Sex Factors | 4 | 2024 | 10622 | 0.190 |
Why?
|
Young Adult | 12 | 2024 | 59980 | 0.190 |
Why?
|
Mississippi | 1 | 2021 | 93 | 0.190 |
Why?
|
Leukocytes | 3 | 2024 | 2034 | 0.190 |
Why?
|
Follow-Up Studies | 7 | 2024 | 39317 | 0.180 |
Why?
|
Self Report | 2 | 2023 | 3773 | 0.180 |
Why?
|
Anti-Inflammatory Agents | 1 | 2010 | 1804 | 0.180 |
Why?
|
alpha Karyopherins | 1 | 2020 | 42 | 0.180 |
Why?
|
Vascular Resistance | 1 | 2024 | 939 | 0.180 |
Why?
|
Albumins | 1 | 2023 | 577 | 0.180 |
Why?
|
ATP-Binding Cassette Transporters | 1 | 2004 | 566 | 0.180 |
Why?
|
Nucleic Acids | 1 | 2023 | 189 | 0.180 |
Why?
|
Vascular Endothelial Growth Factor Receptor-1 | 1 | 2024 | 559 | 0.180 |
Why?
|
Subcutaneous Tissue | 1 | 2021 | 131 | 0.180 |
Why?
|
Aneuploidy | 1 | 2024 | 573 | 0.180 |
Why?
|
Telomere | 2 | 2023 | 943 | 0.180 |
Why?
|
Micronutrients | 1 | 2023 | 390 | 0.170 |
Why?
|
Lipolysis | 1 | 2021 | 211 | 0.170 |
Why?
|
North America | 1 | 2024 | 1287 | 0.170 |
Why?
|
Antibodies, Monoclonal | 2 | 2017 | 9245 | 0.170 |
Why?
|
Lipoprotein Lipase | 2 | 2018 | 133 | 0.170 |
Why?
|
Aged, 80 and over | 8 | 2021 | 59548 | 0.170 |
Why?
|
Multigene Family | 1 | 2023 | 1081 | 0.170 |
Why?
|
Digestive System Diseases | 1 | 2021 | 152 | 0.170 |
Why?
|
Influenza, Human | 1 | 2011 | 1543 | 0.170 |
Why?
|
Heredity | 1 | 2020 | 149 | 0.170 |
Why?
|
Emergency Service, Hospital | 1 | 2019 | 7871 | 0.170 |
Why?
|
Giant Cell Arteritis | 1 | 2024 | 307 | 0.160 |
Why?
|
Dicarboxylic Acids | 1 | 2019 | 75 | 0.160 |
Why?
|
Body Mass Index | 6 | 2024 | 13048 | 0.160 |
Why?
|
Time Factors | 6 | 2024 | 40154 | 0.160 |
Why?
|
Periodontitis | 1 | 2024 | 576 | 0.160 |
Why?
|
Smoking | 4 | 2022 | 9081 | 0.160 |
Why?
|
Birth Weight | 2 | 2024 | 2122 | 0.160 |
Why?
|
Waist-Hip Ratio | 2 | 2017 | 520 | 0.160 |
Why?
|
Blood Glucose | 5 | 2021 | 6421 | 0.160 |
Why?
|
Obesity | 6 | 2024 | 13085 | 0.160 |
Why?
|
Insulin Resistance | 3 | 2024 | 3986 | 0.160 |
Why?
|
DNA Copy Number Variations | 2 | 2018 | 2047 | 0.150 |
Why?
|
Plasminogen Activator Inhibitor 1 | 1 | 2019 | 279 | 0.150 |
Why?
|
Platelet Aggregation | 1 | 2021 | 769 | 0.150 |
Why?
|
Open Reading Frames | 1 | 2021 | 818 | 0.150 |
Why?
|
Databases, Genetic | 3 | 2021 | 1758 | 0.150 |
Why?
|
Urogenital Abnormalities | 1 | 2021 | 255 | 0.150 |
Why?
|
Life Change Events | 1 | 2023 | 956 | 0.150 |
Why?
|
Nutrition Surveys | 2 | 2024 | 1738 | 0.150 |
Why?
|
Africa | 1 | 2020 | 725 | 0.150 |
Why?
|
Activin Receptors, Type I | 1 | 2018 | 133 | 0.150 |
Why?
|
Pathology, Molecular | 1 | 2021 | 328 | 0.150 |
Why?
|
Coronary Circulation | 1 | 2024 | 1603 | 0.150 |
Why?
|
Adenosine Triphosphate | 1 | 2004 | 2001 | 0.140 |
Why?
|
Eye Proteins | 1 | 2021 | 628 | 0.140 |
Why?
|
Ovariectomy | 1 | 2019 | 612 | 0.140 |
Why?
|
Benchmarking | 1 | 2024 | 1056 | 0.140 |
Why?
|
Aspirin | 3 | 2024 | 3135 | 0.140 |
Why?
|
Signal Transduction | 6 | 2024 | 23621 | 0.140 |
Why?
|
Hospital Records | 1 | 2017 | 93 | 0.140 |
Why?
|
Pancreatitis | 1 | 2024 | 1087 | 0.140 |
Why?
|
Risk | 8 | 2021 | 9606 | 0.140 |
Why?
|
Nitric Oxide Synthase Type III | 2 | 2017 | 706 | 0.140 |
Why?
|
Angiopoietins | 1 | 2017 | 86 | 0.140 |
Why?
|
Transendothelial and Transepithelial Migration | 1 | 2017 | 100 | 0.140 |
Why?
|
Idiopathic Pulmonary Fibrosis | 1 | 2022 | 521 | 0.130 |
Why?
|
Serine Proteinase Inhibitors | 1 | 2017 | 174 | 0.130 |
Why?
|
Precancerous Conditions | 1 | 2023 | 980 | 0.130 |
Why?
|
Serine Endopeptidases | 1 | 2021 | 1027 | 0.130 |
Why?
|
Apolipoprotein E2 | 1 | 2016 | 134 | 0.130 |
Why?
|
Cardiomyopathy, Dilated | 1 | 2022 | 843 | 0.130 |
Why?
|
Proteins | 2 | 2023 | 6001 | 0.130 |
Why?
|
Incidental Findings | 1 | 2021 | 698 | 0.130 |
Why?
|
Mice, Knockout | 9 | 2024 | 14476 | 0.130 |
Why?
|
Heart Valve Diseases | 1 | 2023 | 1029 | 0.130 |
Why?
|
Gastrointestinal Diseases | 1 | 2024 | 1205 | 0.130 |
Why?
|
Gene Silencing | 3 | 2020 | 1505 | 0.130 |
Why?
|
CCAAT-Enhancer-Binding Proteins | 1 | 2016 | 287 | 0.120 |
Why?
|
Epigenomics | 1 | 2021 | 959 | 0.120 |
Why?
|
Gout | 1 | 2022 | 620 | 0.120 |
Why?
|
Organ Size | 1 | 2020 | 2264 | 0.120 |
Why?
|
Heart Defects, Congenital | 2 | 2022 | 4713 | 0.120 |
Why?
|
DNA | 4 | 2023 | 7210 | 0.120 |
Why?
|
Consanguinity | 1 | 2017 | 460 | 0.120 |
Why?
|
Gestational Age | 1 | 2024 | 3618 | 0.120 |
Why?
|
Peptide Hormones | 1 | 2016 | 132 | 0.120 |
Why?
|
Gene Expression | 3 | 2023 | 7587 | 0.120 |
Why?
|
Prevalence | 5 | 2024 | 15851 | 0.120 |
Why?
|
Mass Spectrometry | 2 | 2019 | 2201 | 0.120 |
Why?
|
Blood Platelets | 2 | 2024 | 2464 | 0.120 |
Why?
|
Minority Groups | 1 | 2022 | 1214 | 0.120 |
Why?
|
Adiposity | 1 | 2024 | 1894 | 0.120 |
Why?
|
Diabetes Complications | 1 | 2021 | 1319 | 0.120 |
Why?
|
Macular Degeneration | 1 | 2022 | 1015 | 0.110 |
Why?
|
Myeloproliferative Disorders | 1 | 2020 | 616 | 0.110 |
Why?
|
Gene Expression Regulation | 2 | 2023 | 11923 | 0.110 |
Why?
|
Eligibility Determination | 1 | 2017 | 421 | 0.110 |
Why?
|
Genes, Dominant | 1 | 2016 | 855 | 0.110 |
Why?
|
Heart Arrest | 1 | 2024 | 1516 | 0.110 |
Why?
|
Genetic Testing | 3 | 2024 | 3591 | 0.110 |
Why?
|
Adolescent | 6 | 2023 | 89046 | 0.110 |
Why?
|
Obesity, Abdominal | 1 | 2017 | 373 | 0.110 |
Why?
|
RNA-Binding Proteins | 1 | 2022 | 1889 | 0.110 |
Why?
|
Confidence Intervals | 1 | 2019 | 2920 | 0.110 |
Why?
|
Anemia, Sickle Cell | 1 | 2022 | 1065 | 0.110 |
Why?
|
Androgens | 1 | 2020 | 1281 | 0.110 |
Why?
|
Genes | 1 | 2017 | 1824 | 0.110 |
Why?
|
Magnetic Resonance Imaging, Cine | 1 | 2020 | 1092 | 0.110 |
Why?
|
Cardiomyopathy, Hypertrophic | 1 | 2022 | 1337 | 0.100 |
Why?
|
Biological Transport | 2 | 2010 | 2084 | 0.100 |
Why?
|
Registries | 4 | 2022 | 8351 | 0.100 |
Why?
|
Exercise | 3 | 2024 | 5954 | 0.100 |
Why?
|
Homozygote | 1 | 2017 | 1774 | 0.100 |
Why?
|
Tomography, Optical Coherence | 2 | 2024 | 2954 | 0.100 |
Why?
|
Recurrence | 1 | 2024 | 8504 | 0.100 |
Why?
|
Osteoporosis | 1 | 2021 | 1604 | 0.100 |
Why?
|
Pilot Projects | 2 | 2024 | 8732 | 0.100 |
Why?
|
Fatty Acids | 1 | 2019 | 1806 | 0.100 |
Why?
|
DNA Mutational Analysis | 2 | 2017 | 4114 | 0.100 |
Why?
|
Oligonucleotide Array Sequence Analysis | 2 | 2016 | 3797 | 0.090 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2021 | 2902 | 0.090 |
Why?
|
Sphingosine | 1 | 2013 | 306 | 0.090 |
Why?
|
Stem Cells | 1 | 2024 | 3535 | 0.090 |
Why?
|
Lysophospholipids | 1 | 2013 | 336 | 0.090 |
Why?
|
Severity of Illness Index | 4 | 2024 | 15925 | 0.090 |
Why?
|
Aortic Aneurysm, Abdominal | 1 | 2020 | 1250 | 0.090 |
Why?
|
Neoplasms | 5 | 2024 | 22350 | 0.090 |
Why?
|
Acetyl-CoA C-Acetyltransferase | 1 | 2010 | 8 | 0.090 |
Why?
|
Point Mutation | 1 | 2016 | 1591 | 0.090 |
Why?
|
Analysis of Variance | 1 | 2019 | 6215 | 0.090 |
Why?
|
Genetic Markers | 1 | 2016 | 2602 | 0.090 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 2020 | 2887 | 0.090 |
Why?
|
Ventricular Dysfunction, Left | 1 | 2021 | 2144 | 0.090 |
Why?
|
Base Sequence | 2 | 2018 | 12414 | 0.090 |
Why?
|
Kidney Diseases | 1 | 2021 | 2099 | 0.090 |
Why?
|
Health Care Costs | 1 | 2023 | 3239 | 0.090 |
Why?
|
Age Factors | 3 | 2024 | 18401 | 0.090 |
Why?
|
Databases, Factual | 3 | 2021 | 8068 | 0.090 |
Why?
|
Kidney Failure, Chronic | 1 | 2022 | 2495 | 0.080 |
Why?
|
Survival Rate | 2 | 2021 | 12823 | 0.080 |
Why?
|
Premature Birth | 1 | 2022 | 1830 | 0.080 |
Why?
|
Endothelium, Vascular | 2 | 2013 | 4424 | 0.080 |
Why?
|
Gene Deletion | 1 | 2017 | 2668 | 0.080 |
Why?
|
Niacin | 1 | 2010 | 116 | 0.080 |
Why?
|
Molecular Targeted Therapy | 1 | 2020 | 2824 | 0.080 |
Why?
|
Internship and Residency | 1 | 2009 | 5947 | 0.080 |
Why?
|
Osteoclasts | 2 | 2024 | 713 | 0.080 |
Why?
|
Neutrophils | 1 | 2021 | 3779 | 0.080 |
Why?
|
Molecular Sequence Annotation | 2 | 2021 | 526 | 0.080 |
Why?
|
Nitric Oxide | 1 | 2017 | 2140 | 0.080 |
Why?
|
Patient Discharge | 1 | 2021 | 3467 | 0.080 |
Why?
|
Mental Health | 1 | 2023 | 3272 | 0.080 |
Why?
|
Nerve Tissue Proteins | 1 | 2021 | 4401 | 0.080 |
Why?
|
Estonia | 2 | 2018 | 56 | 0.070 |
Why?
|
Coronary Restenosis | 1 | 2010 | 396 | 0.070 |
Why?
|
Vitamin B Complex | 1 | 2010 | 299 | 0.070 |
Why?
|
Glycemic Index | 1 | 2010 | 400 | 0.070 |
Why?
|
Audiovisual Aids | 1 | 2008 | 97 | 0.070 |
Why?
|
Postprandial Period | 2 | 2021 | 320 | 0.070 |
Why?
|
Thiazolidinediones | 1 | 2010 | 460 | 0.070 |
Why?
|
Pulmonary Disease, Chronic Obstructive | 1 | 2022 | 3253 | 0.070 |
Why?
|
Anatomy | 1 | 2008 | 126 | 0.070 |
Why?
|
Survival Analysis | 1 | 2019 | 10092 | 0.070 |
Why?
|
Patient Readmission | 1 | 2020 | 3283 | 0.070 |
Why?
|
Health Services Accessibility | 1 | 2023 | 5519 | 0.060 |
Why?
|
Multiple Myeloma | 1 | 2024 | 5186 | 0.060 |
Why?
|
Ventricular Function, Left | 3 | 2024 | 3934 | 0.060 |
Why?
|
Inpatients | 1 | 2017 | 2563 | 0.060 |
Why?
|
Tomography, X-Ray Computed | 2 | 2021 | 20741 | 0.060 |
Why?
|
Sample Size | 2 | 2021 | 845 | 0.060 |
Why?
|
Hospitalists | 1 | 2009 | 294 | 0.060 |
Why?
|
Hematopoietic Stem Cell Transplantation | 1 | 2024 | 5716 | 0.060 |
Why?
|
Polymorphism, Genetic | 3 | 2022 | 4247 | 0.060 |
Why?
|
Diabetic Angiopathies | 1 | 2010 | 806 | 0.060 |
Why?
|
American Heart Association | 2 | 2022 | 1049 | 0.060 |
Why?
|
Biomedical Research | 1 | 2020 | 3464 | 0.060 |
Why?
|
Chronic Disease | 1 | 2019 | 9362 | 0.060 |
Why?
|
Glomerular Filtration Rate | 2 | 2023 | 2227 | 0.060 |
Why?
|
Demography | 2 | 2021 | 1641 | 0.060 |
Why?
|
Protein Conformation | 3 | 2014 | 3948 | 0.060 |
Why?
|
Epigenesis, Genetic | 3 | 2024 | 3828 | 0.060 |
Why?
|
Referral and Consultation | 1 | 2017 | 3618 | 0.060 |
Why?
|
Age of Onset | 2 | 2024 | 3344 | 0.060 |
Why?
|
HSP27 Heat-Shock Proteins | 1 | 2024 | 66 | 0.060 |
Why?
|
Ribonucleases | 1 | 2024 | 266 | 0.060 |
Why?
|
Retrospective Studies | 9 | 2025 | 81659 | 0.060 |
Why?
|
Tandem Mass Spectrometry | 2 | 2022 | 1197 | 0.060 |
Why?
|
Monocarboxylic Acid Transporters | 1 | 2023 | 81 | 0.050 |
Why?
|
Myocytes, Cardiac | 2 | 2024 | 1672 | 0.050 |
Why?
|
Chromosomes, Human, Y | 1 | 2024 | 163 | 0.050 |
Why?
|
Chromosome Segregation | 1 | 2024 | 230 | 0.050 |
Why?
|
Physics | 1 | 2023 | 92 | 0.050 |
Why?
|
Video Recording | 1 | 2008 | 977 | 0.050 |
Why?
|
Depression | 1 | 2023 | 8234 | 0.050 |
Why?
|
Aptamers, Peptide | 1 | 2022 | 28 | 0.050 |
Why?
|
Pedigree | 2 | 2023 | 4539 | 0.050 |
Why?
|
F-Box Proteins | 1 | 2024 | 199 | 0.050 |
Why?
|
3' Untranslated Regions | 1 | 2024 | 515 | 0.050 |
Why?
|
Delivery of Health Care | 1 | 2020 | 5363 | 0.050 |
Why?
|
Child | 4 | 2023 | 80771 | 0.050 |
Why?
|
Fibrillar Collagens | 1 | 2022 | 42 | 0.050 |
Why?
|
Bradycardia | 1 | 2024 | 305 | 0.050 |
Why?
|
Mucin-5B | 1 | 2022 | 148 | 0.050 |
Why?
|
Transcription Factors | 2 | 2023 | 12158 | 0.050 |
Why?
|
Infant, Newborn | 4 | 2024 | 26396 | 0.050 |
Why?
|
Alzheimer Disease | 1 | 2023 | 8717 | 0.050 |
Why?
|
Mice, Inbred C57BL | 4 | 2024 | 22361 | 0.050 |
Why?
|
Arabs | 1 | 2023 | 190 | 0.050 |
Why?
|
Peptides | 2 | 2004 | 4348 | 0.050 |
Why?
|
Sulfhydryl Compounds | 1 | 2002 | 296 | 0.050 |
Why?
|
Protein Structure, Secondary | 1 | 2004 | 1211 | 0.050 |
Why?
|
Sitosterols | 1 | 2020 | 9 | 0.050 |
Why?
|
Prostatic Neoplasms | 1 | 2023 | 11097 | 0.050 |
Why?
|
Chromosome Mapping | 2 | 2021 | 4616 | 0.040 |
Why?
|
Antineoplastic Agents | 1 | 2023 | 13650 | 0.040 |
Why?
|
Population Groups | 1 | 2021 | 209 | 0.040 |
Why?
|
Blood Cell Count | 1 | 2021 | 404 | 0.040 |
Why?
|
Cytochrome P-450 CYP2D6 | 1 | 2021 | 108 | 0.040 |
Why?
|
Phytosterols | 1 | 2020 | 55 | 0.040 |
Why?
|
Platelet Activation | 1 | 2024 | 643 | 0.040 |
Why?
|
Alendronate | 1 | 2021 | 174 | 0.040 |
Why?
|
Population Density | 1 | 2021 | 193 | 0.040 |
Why?
|
Bone Resorption | 1 | 2024 | 726 | 0.040 |
Why?
|
Genetic Counseling | 1 | 2024 | 635 | 0.040 |
Why?
|
Japan | 1 | 2024 | 1418 | 0.040 |
Why?
|
Membrane Transport Proteins | 2 | 2016 | 1029 | 0.040 |
Why?
|
Fractional Flow Reserve, Myocardial | 1 | 2024 | 348 | 0.040 |
Why?
|
INDEL Mutation | 1 | 2021 | 266 | 0.040 |
Why?
|
Magnesium | 1 | 2023 | 815 | 0.040 |
Why?
|
Critical Pathways | 1 | 2023 | 476 | 0.040 |
Why?
|
Lipid Metabolism, Inborn Errors | 1 | 2020 | 122 | 0.040 |
Why?
|
Lipoproteins, LDL | 1 | 2023 | 640 | 0.040 |
Why?
|
Cell Lineage | 2 | 2020 | 2575 | 0.040 |
Why?
|
Vero Cells | 1 | 2020 | 486 | 0.040 |
Why?
|
Policy | 1 | 2023 | 513 | 0.040 |
Why?
|
Italy | 1 | 2021 | 856 | 0.040 |
Why?
|
Adenosine Triphosphatases | 1 | 2023 | 840 | 0.040 |
Why?
|
Troponin T | 1 | 2024 | 786 | 0.040 |
Why?
|
Norway | 1 | 2020 | 500 | 0.040 |
Why?
|
Education, Medical, Undergraduate | 1 | 2008 | 1087 | 0.040 |
Why?
|
von Willebrand Factor | 1 | 2023 | 680 | 0.040 |
Why?
|
Retinal Pigment Epithelium | 1 | 2022 | 309 | 0.040 |
Why?
|
Factor V | 1 | 2019 | 168 | 0.040 |
Why?
|
Stents | 1 | 2010 | 3193 | 0.040 |
Why?
|
Protein Transport | 1 | 2004 | 1944 | 0.040 |
Why?
|
Lung Neoplasms | 1 | 2022 | 13491 | 0.040 |
Why?
|
Interleukin-17 | 1 | 2024 | 922 | 0.040 |
Why?
|
Quality Control | 1 | 2021 | 835 | 0.040 |
Why?
|
Ventricular Function, Right | 1 | 2022 | 629 | 0.040 |
Why?
|
Peripheral Vascular Diseases | 1 | 2021 | 488 | 0.040 |
Why?
|
Program Evaluation | 2 | 2021 | 2505 | 0.040 |
Why?
|
Membrane Proteins | 1 | 2014 | 7868 | 0.040 |
Why?
|
Kidney | 2 | 2023 | 7063 | 0.040 |
Why?
|
Face | 1 | 2024 | 1029 | 0.040 |
Why?
|
Multivariate Analysis | 2 | 2024 | 12069 | 0.040 |
Why?
|
Liposomes | 1 | 2021 | 787 | 0.040 |
Why?
|
Europe | 1 | 2024 | 3432 | 0.040 |
Why?
|
Cells, Cultured | 3 | 2020 | 18989 | 0.040 |
Why?
|
Neuregulins | 1 | 2017 | 36 | 0.040 |
Why?
|
Leukocyte Rolling | 1 | 2017 | 69 | 0.040 |
Why?
|
Gene Targeting | 1 | 2020 | 841 | 0.040 |
Why?
|
Radiographic Image Interpretation, Computer-Assisted | 1 | 2024 | 1233 | 0.040 |
Why?
|
Osteogenesis | 1 | 2024 | 1285 | 0.040 |
Why?
|
Parity | 1 | 2020 | 931 | 0.030 |
Why?
|
Causality | 1 | 2023 | 1253 | 0.030 |
Why?
|
Workflow | 1 | 2022 | 859 | 0.030 |
Why?
|
Postpartum Period | 1 | 2024 | 1198 | 0.030 |
Why?
|
Mutagenesis | 1 | 2021 | 1227 | 0.030 |
Why?
|
1-Alkyl-2-acetylglycerophosphocholine Esterase | 1 | 2017 | 127 | 0.030 |
Why?
|
Linkage Disequilibrium | 1 | 2021 | 1996 | 0.030 |
Why?
|
Adaptor Proteins, Vesicular Transport | 1 | 2018 | 301 | 0.030 |
Why?
|
Arteries | 1 | 2021 | 1123 | 0.030 |
Why?
|
Area Under Curve | 1 | 2021 | 1639 | 0.030 |
Why?
|
Interleukins | 1 | 2021 | 796 | 0.030 |
Why?
|
Lipoproteins, VLDL | 1 | 2017 | 198 | 0.030 |
Why?
|
Interleukin-1beta | 1 | 2022 | 1027 | 0.030 |
Why?
|
GATA2 Transcription Factor | 1 | 2016 | 158 | 0.030 |
Why?
|
Respiratory Hypersensitivity | 1 | 2018 | 271 | 0.030 |
Why?
|
Delivery of Health Care, Integrated | 1 | 2024 | 951 | 0.030 |
Why?
|
Uric Acid | 1 | 2022 | 805 | 0.030 |
Why?
|
Cluster Analysis | 1 | 2023 | 2721 | 0.030 |
Why?
|
Molecular Diagnostic Techniques | 1 | 2021 | 615 | 0.030 |
Why?
|
Pakistan | 1 | 2017 | 299 | 0.030 |
Why?
|
RNA Splice Sites | 1 | 2017 | 212 | 0.030 |
Why?
|
Leukemia | 1 | 2024 | 1518 | 0.030 |
Why?
|
Breast Neoplasms | 1 | 2023 | 21178 | 0.030 |
Why?
|
Massachusetts | 2 | 2020 | 8890 | 0.030 |
Why?
|
Multicenter Studies as Topic | 1 | 2021 | 1733 | 0.030 |
Why?
|
Intestinal Diseases | 1 | 2020 | 505 | 0.030 |
Why?
|
Databases, Nucleic Acid | 1 | 2016 | 203 | 0.030 |
Why?
|
Executive Function | 1 | 2024 | 1396 | 0.030 |
Why?
|
Organ Specificity | 1 | 2020 | 1966 | 0.030 |
Why?
|
Sequence Analysis | 1 | 2016 | 240 | 0.030 |
Why?
|
Drug Evaluation, Preclinical | 1 | 2020 | 1331 | 0.030 |
Why?
|
Liver | 2 | 2021 | 7578 | 0.030 |
Why?
|
Computer Simulation | 2 | 2020 | 6260 | 0.030 |
Why?
|
Sulfonylurea Compounds | 1 | 2017 | 220 | 0.030 |
Why?
|
Pulmonary Artery | 1 | 2024 | 1944 | 0.030 |
Why?
|
Metabolome | 1 | 2022 | 1008 | 0.030 |
Why?
|
Prediabetic State | 1 | 2021 | 547 | 0.030 |
Why?
|
Glycoproteins | 1 | 2023 | 2200 | 0.030 |
Why?
|
Insurance, Pharmaceutical Services | 1 | 2017 | 348 | 0.030 |
Why?
|
Income | 1 | 2023 | 1877 | 0.030 |
Why?
|
Social Class | 1 | 2023 | 2007 | 0.030 |
Why?
|
Haplotypes | 1 | 2021 | 2722 | 0.030 |
Why?
|
Antioxidants | 1 | 2002 | 1671 | 0.030 |
Why?
|
Epistasis, Genetic | 1 | 2016 | 353 | 0.030 |
Why?
|
Basophils | 1 | 2016 | 407 | 0.030 |
Why?
|
Radiology | 1 | 2008 | 2106 | 0.030 |
Why?
|
Organoids | 1 | 2020 | 740 | 0.030 |
Why?
|
Linear Models | 1 | 2024 | 5875 | 0.030 |
Why?
|
Antibodies | 1 | 2022 | 2419 | 0.030 |
Why?
|
DNA Repair | 1 | 2023 | 2050 | 0.030 |
Why?
|
Immunoblotting | 1 | 2017 | 1647 | 0.030 |
Why?
|
Insurance, Health, Reimbursement | 1 | 2017 | 388 | 0.030 |
Why?
|
Interleukin-8 | 1 | 2017 | 704 | 0.030 |
Why?
|
Potassium Channels | 1 | 2016 | 534 | 0.030 |
Why?
|
Angiotensin-Converting Enzyme Inhibitors | 1 | 2020 | 1515 | 0.030 |
Why?
|
Amino Acid Substitution | 1 | 2018 | 1743 | 0.030 |
Why?
|
Residence Characteristics | 1 | 2023 | 2116 | 0.030 |
Why?
|
Clinical Competence | 1 | 2009 | 4859 | 0.030 |
Why?
|
Education | 1 | 2016 | 531 | 0.030 |
Why?
|
Aortic Valve | 1 | 2023 | 1968 | 0.030 |
Why?
|
Chromatography, Liquid | 1 | 2017 | 996 | 0.030 |
Why?
|
Guanine Nucleotide Exchange Factors | 1 | 2017 | 572 | 0.030 |
Why?
|
Acute Disease | 1 | 2024 | 7236 | 0.030 |
Why?
|
Information Dissemination | 1 | 2021 | 1142 | 0.030 |
Why?
|
ROC Curve | 1 | 2021 | 3618 | 0.030 |
Why?
|
Leukocyte Count | 1 | 2016 | 1606 | 0.030 |
Why?
|
Glucose Tolerance Test | 1 | 2016 | 1181 | 0.030 |
Why?
|
Task Performance and Analysis | 1 | 2016 | 771 | 0.030 |
Why?
|
Receptors, Lysosphingolipid | 1 | 2013 | 121 | 0.030 |
Why?
|
Autoimmune Diseases | 1 | 2024 | 2255 | 0.020 |
Why?
|
Up-Regulation | 1 | 2021 | 4143 | 0.020 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2004 | 10748 | 0.020 |
Why?
|
Regulatory Sequences, Nucleic Acid | 1 | 2015 | 792 | 0.020 |
Why?
|
Androgen Antagonists | 1 | 2020 | 1412 | 0.020 |
Why?
|
Cell Differentiation | 2 | 2021 | 11657 | 0.020 |
Why?
|
Promoter Regions, Genetic | 1 | 2023 | 5796 | 0.020 |
Why?
|
Cytoskeletal Proteins | 1 | 2017 | 1326 | 0.020 |
Why?
|
Antibodies, Neutralizing | 1 | 2021 | 2011 | 0.020 |
Why?
|
Guideline Adherence | 1 | 2022 | 2232 | 0.020 |
Why?
|
Echocardiography | 1 | 2024 | 5042 | 0.020 |
Why?
|
Neuropsychological Tests | 1 | 2024 | 7121 | 0.020 |
Why?
|
Muscle Proteins | 1 | 2016 | 1160 | 0.020 |
Why?
|
Algorithms | 2 | 2024 | 14098 | 0.020 |
Why?
|
Pregnancy Outcome | 1 | 2022 | 2972 | 0.020 |
Why?
|
Rare Diseases | 1 | 2016 | 630 | 0.020 |
Why?
|
Fasting | 1 | 2017 | 1607 | 0.020 |
Why?
|
Chromatin | 1 | 2022 | 2980 | 0.020 |
Why?
|
T-Lymphocytes, Regulatory | 1 | 2024 | 3114 | 0.020 |
Why?
|
Anilides | 1 | 2013 | 413 | 0.020 |
Why?
|
Enhancer Elements, Genetic | 1 | 2016 | 1366 | 0.020 |
Why?
|
Socioeconomic Factors | 1 | 2023 | 7848 | 0.020 |
Why?
|
Artificial Intelligence | 1 | 2024 | 2666 | 0.020 |
Why?
|
Patient Acceptance of Health Care | 1 | 2023 | 3232 | 0.020 |
Why?
|
Computational Biology | 1 | 2021 | 3567 | 0.020 |
Why?
|
Drug Costs | 1 | 2017 | 1196 | 0.020 |
Why?
|
Dietary Fats | 1 | 2017 | 2001 | 0.020 |
Why?
|
Heart | 1 | 2022 | 4429 | 0.020 |
Why?
|
Kaplan-Meier Estimate | 1 | 2019 | 6513 | 0.020 |
Why?
|
Exons | 1 | 2014 | 2391 | 0.020 |
Why?
|
Healthcare Disparities | 1 | 2024 | 3414 | 0.020 |
Why?
|
Treatment Outcome | 3 | 2021 | 65295 | 0.020 |
Why?
|
Transcription, Genetic | 1 | 2022 | 7611 | 0.020 |
Why?
|
Nuclear Proteins | 1 | 2023 | 5794 | 0.020 |
Why?
|
DNA Methylation | 1 | 2022 | 4426 | 0.020 |
Why?
|
Antiviral Agents | 1 | 2020 | 3070 | 0.020 |
Why?
|
Phosphoproteins | 1 | 2017 | 2448 | 0.020 |
Why?
|
HEK293 Cells | 1 | 2017 | 4280 | 0.020 |
Why?
|
Positron-Emission Tomography | 1 | 2024 | 6550 | 0.020 |
Why?
|
RNA, Messenger | 1 | 2022 | 12793 | 0.020 |
Why?
|
Homeostasis | 1 | 2018 | 3345 | 0.020 |
Why?
|
Primary Health Care | 1 | 2023 | 4746 | 0.020 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2023 | 10393 | 0.020 |
Why?
|
Arthritis, Rheumatoid | 1 | 2022 | 3778 | 0.020 |
Why?
|
Body Weight | 1 | 2017 | 4627 | 0.020 |
Why?
|
Patient Compliance | 1 | 2016 | 2697 | 0.020 |
Why?
|
Neovascularization, Physiologic | 1 | 2013 | 1368 | 0.020 |
Why?
|
Comorbidity | 1 | 2020 | 10582 | 0.020 |
Why?
|
Gene Expression Regulation, Developmental | 1 | 2016 | 3610 | 0.020 |
Why?
|
Disease Models, Animal | 1 | 2024 | 18330 | 0.020 |
Why?
|
Mice, Transgenic | 1 | 2017 | 9551 | 0.010 |
Why?
|
Cost-Benefit Analysis | 1 | 2017 | 5537 | 0.010 |
Why?
|
Societies, Medical | 1 | 2016 | 3964 | 0.010 |
Why?
|
Proto-Oncogene Proteins c-akt | 1 | 2013 | 2457 | 0.010 |
Why?
|
Hypoglycemic Agents | 1 | 2017 | 3108 | 0.010 |
Why?
|
Carrier Proteins | 1 | 2017 | 4925 | 0.010 |
Why?
|
Lipoxygenase | 1 | 2002 | 72 | 0.010 |
Why?
|
Hospitalization | 1 | 2022 | 10815 | 0.010 |
Why?
|
Logistic Models | 1 | 2017 | 13284 | 0.010 |
Why?
|
Insulin | 1 | 2017 | 6602 | 0.010 |
Why?
|
Phosphorylation | 1 | 2013 | 8310 | 0.010 |
Why?
|
Program Development | 1 | 2008 | 1298 | 0.010 |
Why?
|
Lipid Peroxidation | 1 | 2002 | 276 | 0.010 |
Why?
|
Cell Movement | 1 | 2013 | 5203 | 0.010 |
Why?
|
Educational Measurement | 1 | 2008 | 1259 | 0.010 |
Why?
|
Glutathione | 1 | 2002 | 589 | 0.010 |
Why?
|
Infant | 1 | 2021 | 36485 | 0.010 |
Why?
|
Medicare | 1 | 2017 | 6813 | 0.010 |
Why?
|
Child, Preschool | 1 | 2021 | 42606 | 0.010 |
Why?
|
Cysteine | 1 | 2002 | 896 | 0.010 |
Why?
|
Cell Proliferation | 1 | 2013 | 10455 | 0.010 |
Why?
|
Curriculum | 1 | 2008 | 3786 | 0.010 |
Why?
|
Cell Line | 1 | 2002 | 15567 | 0.000 |
Why?
|
Macrophages | 1 | 2002 | 5785 | 0.000 |
Why?
|